BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rapisarda V, Loreto C, Malaguarnera M, Ardiri A, Proiti M, Rigano G, Frazzetto E, Ruggeri MI, Malaguarnera G, Bertino N, Malaguarnera M, Catania VE, Di Carlo I, Toro A, Bertino E, Mangano D, Bertino G. Hepatocellular carcinoma and the risk of occupational exposure. World J Hepatol 2016; 8(13): 573-590 [PMID: 27168870 DOI: 10.4254/wjh.v8.i13.573] [Cited by in CrossRef: 44] [Cited by in F6Publishing: 40] [Article Influence: 7.3] [Reference Citation Analysis]
Number Citing Articles
1 Wang F, Qi X, Li Z, Jin S, Xie Y, Zhong H. lncRNA CADM1-AS1 inhibits cell-cycle progression and invasion via PTEN/AKT/GSK-3β axis in hepatocellular carcinoma. Cancer Manag Res 2019;11:3813-28. [PMID: 31118799 DOI: 10.2147/CMAR.S197673] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
2 Liu W, Wang L, Zheng C, Liu L, Wang J, Li D, Tan Y, Zhao X, He L, Shu W. Microcystin-LR increases genotoxicity induced by aflatoxin B1 through oxidative stress and DNA base excision repair genes in human hepatic cell lines. Environ Pollut 2018;233:455-63. [PMID: 29100183 DOI: 10.1016/j.envpol.2017.10.067] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 4.8] [Reference Citation Analysis]
3 Sun D, Lu J, Hu C, Zhang Q, Wang X, Zhang Z, Hu S. Prognostic role of miR-760 in hepatocellular carcinoma. Oncol Lett. 2018;16:7239-7244. [PMID: 30546462 DOI: 10.3892/ol.2018.9546] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
4 Janitz AE, Ramachandran G, Tomlinson GE, Krailo M, Richardson M, Spector L. Maternal and paternal occupational exposures and hepatoblastoma: results from the HOPE study through the Children's Oncology Group. J Expo Sci Environ Epidemiol 2017;27:359-64. [PMID: 28272399 DOI: 10.1038/jes.2017.1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
5 Wang YG, Wang T, Shi M, Zhai B. Long noncoding RNA EPB41L4A-AS2 inhibits hepatocellular carcinoma development by sponging miR-301a-5p and targeting FOXL1. J Exp Clin Cancer Res 2019;38:153. [PMID: 30971290 DOI: 10.1186/s13046-019-1128-9] [Cited by in Crossref: 34] [Cited by in F6Publishing: 44] [Article Influence: 11.3] [Reference Citation Analysis]
6 Zhao W, Guo J, Li H, Cai L, Duan Y, Hou X, Diao Z, Shao X, Du H, Li C. FAM83H-AS1/miR-485-5p/MEF2D axis facilitates proliferation, migration and invasion of hepatocellular carcinoma cells. BMC Cancer 2021;21:1310. [PMID: 34876040 DOI: 10.1186/s12885-021-08923-0] [Reference Citation Analysis]
7 Noviana E, Ozer T, Carrell CS, Link JS, Mcmahon C, Jang I, Henry CS. Microfluidic Paper-Based Analytical Devices: From Design to Applications. Chem Rev 2021;121:11835-85. [DOI: 10.1021/acs.chemrev.0c01335] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
8 Zhang J, Xue F, Chen S, Zhang D, Lu C, Tang G. The influence of caveolin-1 gene polymorphisms on hepatitis B virus-related hepatocellular carcinoma susceptibility in Chinese Han population: A case-control study. Medicine (Baltimore) 2017;96:e7359. [PMID: 29049173 DOI: 10.1097/MD.0000000000007359] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
9 Selvolini G, Marrazza G. MIP-Based Sensors: Promising New Tools for Cancer Biomarker Determination. Sensors (Basel) 2017;17:E718. [PMID: 28353669 DOI: 10.3390/s17040718] [Cited by in Crossref: 66] [Cited by in F6Publishing: 41] [Article Influence: 13.2] [Reference Citation Analysis]
10 Malaguarnera G, Bertino G, Chisari G, Motta M, Vecchio M, Vacante M, Caraci F, Greco C, Drago F, Nunnari G, Malaguarnera M. Silybin supplementation during HCV therapy with pegylated interferon-α plus ribavirin reduces depression and anxiety and increases work ability. BMC Psychiatry 2016;16:398. [PMID: 27842532 DOI: 10.1186/s12888-016-1115-z] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
11 Yang X, Song D, Zhang J, Yang X, Feng H, Guo J. PRR34-AS1 sponges miR-498 to facilitate TOMM20 and ITGA6 mediated tumor progression in HCC. Exp Mol Pathol 2021;120:104620. [PMID: 33609562 DOI: 10.1016/j.yexmp.2021.104620] [Reference Citation Analysis]
12 Najafi A, Behnam B, Jafari E, Anani H, Karami-mohajeri S. Aminoguanidine induced apoptosis in human hepatocarcinoma HepG2 cells. Gene Reports 2021;25:101329. [DOI: 10.1016/j.genrep.2021.101329] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Sui C, Zhuang C, Sun D, Yang L, Zhang L, Song L. Notch1 regulates the JNK signaling pathway and increases apoptosis in hepatocellular carcinoma. Oncotarget 2017;8:45837-47. [PMID: 28507277 DOI: 10.18632/oncotarget.17434] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 3.3] [Reference Citation Analysis]
14 Zhang L, Yan L, Niu H, Ma J, Yuan BY, Chen YH, Zhuang Y, Hu Y, Zeng ZC, Xiang ZL. A nomogram to predict prognosis of patients with unresected hepatocellular carcinoma undergoing radiotherapy: a population-based study. J Cancer 2019;10:4564-73. [PMID: 31528220 DOI: 10.7150/jca.30365] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
15 Latteri S, Malaguarnera G, Catania VE, La Greca G, Bertino G, Borzì AM, Drago F, Malaguarnera M. Homocysteine Serum Levels as Prognostic Marker of Hepatocellular Carcinoma with Portal Vein Thrombosis. Curr Mol Med 2019;19:532-8. [PMID: 31187711 DOI: 10.2174/1566524019666190610120416] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Gorini F, Bustaffa E, Bolignano D, Cori L, Faita F, Gastaldelli A, Interdonato M, Minichilli F, Quattrone G, Squadrito F, Tripepi G, Vassalle C, Bianchi F. Biomarkers of exposure and early effect in three contaminated sites of southern Italy: protocols for etiological epidemiological studies. BMJ Open 2020;10:e036160. [PMID: 32393613 DOI: 10.1136/bmjopen-2019-036160] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
17 Tayefinasrabadi H, Mohebbi SR, Hosseini SM, Azimzadeh P, Pourhoseingholi MA, Ghaemi A, Sharifian A, Asadzadeh Aghdaei H, Zali MR. Association of Interleukin-17 gene polymorphisms with susceptibility to chronic hepatitis B virus infection and clearance in Iranian population. Microb Pathog 2020;144:104195. [PMID: 32294519 DOI: 10.1016/j.micpath.2020.104195] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
18 Ai J, Ketabchi N, Verdi J, Gheibi N, Khadem Haghighian H, Kavianpour M. Mesenchymal stromal cells induce inhibitory effects on hepatocellular carcinoma through various signaling pathways. Cancer Cell Int 2019;19:329. [PMID: 31827403 DOI: 10.1186/s12935-019-1038-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
19 Bertino G, Malaguarnera G, Frazzetto E, Sciuto A, Inserra G, Zanghì GN, Malaguarnera M. Responsibility of hepatitis C virus in the development of hepatocellular carcinoma: From molecular alterations to possible solutions. World J Hepatol 2018; 10(6): 448-451 [PMID: 29988862 DOI: 10.4254/wjh.v10.i6.448] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
20 Malaguarnera G, Catania VE, Francaviglia A, Malaguarnera M, Drago F, Motta M, Latteri S. Lipoprotein(a) in patients with hepatocellular carcinoma and portal vein thrombosis. Aging Clin Exp Res. 2017;29:185-190. [PMID: 27822883 DOI: 10.1007/s40520-016-0653-z] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
21 Wang J, Pu J, Yao T, Lu X, Deng Y. Four long noncoding RNAs as potential prognostic biomarkers for hepatocellular carcinoma. J Cell Physiol 2019;234:8709-16. [PMID: 30417366 DOI: 10.1002/jcp.27530] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
22 Zhao J, Chen HQ, Yang HF, Li XY, Liu WB. Gene expression network related to DNA methylation and miRNA regulation during the process of aflatoxin B1-induced malignant transformation of L02 cells. J Appl Toxicol 2021. [PMID: 34561900 DOI: 10.1002/jat.4233] [Reference Citation Analysis]
23 Huang CF, Yeh ML, Huang CY, Tsai PC, Ko YM, Chen KY, Lin ZY, Chen SC, Dai CY, Chuang WL, Huang JF, Yu ML. Pretreatment glucose status determines HCC development in HCV patients with mild liver disease after curative antiviral therapy. Medicine (Baltimore) 2016;95:e4157. [PMID: 27399135 DOI: 10.1097/MD.0000000000004157] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 3.8] [Reference Citation Analysis]
24 Xiao Q, Fu B, Chen P, Liu ZZ, Wang W, Ye Q. Three polymorphisms of tumor necrosis factor-alpha and hepatitis B virus related hepatocellular carcinoma: A meta-analysis. Medicine (Baltimore) 2016;95:e5609. [PMID: 27977601 DOI: 10.1097/MD.0000000000005609] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
25 Srisomwat C, Yakoh A, Chuaypen N, Tangkijvanich P, Vilaivan T, Chailapakul O. Amplification-free DNA Sensor for the One-Step Detection of the Hepatitis B Virus Using an Automated Paper-Based Lateral Flow Electrochemical Device. Anal Chem 2021;93:2879-87. [DOI: 10.1021/acs.analchem.0c04283] [Cited by in Crossref: 9] [Cited by in F6Publishing: 13] [Article Influence: 4.5] [Reference Citation Analysis]
26 Wang L, Han L, Tao Z, Zhu Z, Han L, Yang Z, Wang H, Dai D, Wu L, Yuan Z, Chen T. The curcumin derivative WZ35 activates ROS-dependent JNK to suppress hepatocellular carcinoma metastasis. Food Funct 2018;9:2970-8. [PMID: 29766185 DOI: 10.1039/c8fo00314a] [Cited by in Crossref: 12] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
27 Chen S, Chen Y, Qian Q, Wang X, Chang Y, Ju S, Xu Y, Zhang C, Qin N, Ding H, Gu Y, Han J, Wang C, Zhang E, Hu Z. Gene amplification derived a cancer-testis long noncoding RNA PCAT6 regulates cell proliferation and migration in hepatocellular carcinoma. Cancer Med 2019;8:3017-25. [PMID: 30968586 DOI: 10.1002/cam4.2141] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 4.7] [Reference Citation Analysis]
28 Rashed WM, Kandeil MAM, Mahmoud MO, Ezzat S. Hepatocellular Carcinoma (HCC) in Egypt: A comprehensive overview. J Egypt Natl Canc Inst 2020;32:5. [PMID: 32372179 DOI: 10.1186/s43046-020-0016-x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 13.0] [Reference Citation Analysis]
29 Marchese S, Polo A, Ariano A, Velotto S, Costantini S, Severino L. Aflatoxin B1 and M1: Biological Properties and Their Involvement in Cancer Development. Toxins (Basel) 2018;10:E214. [PMID: 29794965 DOI: 10.3390/toxins10060214] [Cited by in Crossref: 113] [Cited by in F6Publishing: 78] [Article Influence: 28.3] [Reference Citation Analysis]
30 Chen YJ, Shen CJ, Yu SH, Lin CL, Shih HM. Increased risk of hepatocellular carcinoma in patients with traumatic liver injury: Real-world data from a nationwide population-based study. Medicine (Baltimore) 2022;101:e28837. [PMID: 35147128 DOI: 10.1097/MD.0000000000028837] [Reference Citation Analysis]
31 Malaguarnera M, Latteri S, Bertino G, Madeddu R, Catania VE, Currò G, Borzì AM, Drago F, Malaguarnera G. D-dimer plasmatic levels as a marker for diagnosis and prognosis of hepatocellular carcinoma patients with portal vein thrombosis. Clin Exp Gastroenterol 2018;11:373-80. [PMID: 30323642 DOI: 10.2147/CEG.S172663] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
32 Bouet S, Samson E, Jovanovic I, Laurier D, Laurent O. First mortality analysis in the French cohort of uranium millers (F-Millers), period 1968–2013. Int Arch Occup Environ Health 2018;91:23-33. [DOI: 10.1007/s00420-017-1254-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
33 Qu D, Cui F, Lu D, Yang Y, Xu Y. DEP domain containing 1 predicts prognosis of hepatocellular carcinoma patients and regulates tumor proliferation and metastasis. Cancer Sci 2019;110:157-65. [PMID: 30417471 DOI: 10.1111/cas.13867] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
34 Hu X, Li Q, Zhang J. The Long Noncoding RNA LINC00908 Facilitates Hepatocellular Carcinoma Progression Via Interaction With Sox-4. Cancer Manag Res 2019;11:8789-97. [PMID: 31632138 DOI: 10.2147/CMAR.S216774] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
35 Jin C, Li C, Peng W, Wen TF, Yan LN, Li B, Wang WT, Yang JY, Xu MQ. Changes of platelet times neutrophil to lymphocyte ratio predict BCLC stage A hepatocellular carcinoma survival. Medicine (Baltimore). 2017;96:e7821. [PMID: 28816981 DOI: 10.1097/md.0000000000007821] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
36 Al-Khazraji A. Cutaneous manifestations of hepatocellular cancer (HCC). Expert Rev Gastroenterol Hepatol 2016;10:1075-7. [PMID: 27558446 DOI: 10.1080/17474124.2016.1229182] [Reference Citation Analysis]
37 Malaguarnera M, Catania VE, Borzì AM, Malaguarnera S, Madeddu R, Bertino G, Latteri S. Blood homocysteine levels are increased in hepatocellular carcinoma patients with portal vein thrombosis. A single centre retrospective cohort study. International Journal of Surgery Open 2018;15:60-5. [DOI: 10.1016/j.ijso.2018.11.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
38 European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu., Clinical Practice Guideline Panel: Chair:., Panel members:., EASL Governing Board representative:. EASL Clinical Practice Guideline: Occupational liver diseases. J Hepatol 2019;71:1022-37. [PMID: 31540728 DOI: 10.1016/j.jhep.2019.08.008] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
39 Hu JH, Chen MY, Yeh CT, Chiu WN, Chiang MS, Chang ML. Effects of gender and age on prevalence of cholelithiasis in patients with chronic HCV infection: A community-based cross-sectional study in an HCV-hyperendemic area. Medicine (Baltimore) 2018;97:e10846. [PMID: 29851796 DOI: 10.1097/MD.0000000000010846] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
40 Xie J, Zhang A, Wang X. Metabolomic applications in hepatocellular carcinoma: toward the exploration of therapeutics and diagnosis through small molecules. RSC Adv 2017;7:17217-26. [DOI: 10.1039/c7ra00698e] [Cited by in Crossref: 13] [Article Influence: 2.6] [Reference Citation Analysis]
41 Srisomwat C, Teengam P, Chuaypen N, Tangkijvanich P, Vilaivan T, Chailapakul O. Pop-up paper electrochemical device for label-free hepatitis B virus DNA detection. Sensors and Actuators B: Chemical 2020;316:128077. [DOI: 10.1016/j.snb.2020.128077] [Cited by in Crossref: 23] [Cited by in F6Publishing: 8] [Article Influence: 11.5] [Reference Citation Analysis]
42 Suk WA, Bhudhisawasdi V, Ruchirawat M. The Curious Case of Cholangiocarcinoma: Opportunities for Environmental Health Scientists to Learn about a Complex Disease. J Environ Public Health 2018;2018:2606973. [PMID: 30158988 DOI: 10.1155/2018/2606973] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
43 Tsai TY, Lin CC, Peng CY, Huang WH, Su WP, Lai SW, Chen HJ, Lai HC. The association between biliary tract inflammation and risk of digestive system cancers: A population-based cohort study. Medicine (Baltimore) 2016;95:e4427. [PMID: 27495065 DOI: 10.1097/MD.0000000000004427] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 3.4] [Reference Citation Analysis]
44 Xue M, Lin X, Lin QX, Pu X, Liu J, Li XF, Hou J, Liu X, Chen R. Association between hepatitis B and E virus infection and hepatocellular carcinoma risk. Int J Cancer 2021;148:2974-81. [PMID: 33554326 DOI: 10.1002/ijc.33505] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
45 Zhang J, Li Z, Liu L, Wang Q, Li S, Chen D, Hu Z, Yu T, Ding J, Li J, Yao M, Huang S, Zhao Y, He X. Long noncoding RNA TSLNC8 is a tumor suppressor that inactivates the interleukin-6/STAT3 signaling pathway. Hepatology. 2018;67:171-187. [PMID: 28746790 DOI: 10.1002/hep.29405] [Cited by in Crossref: 103] [Cited by in F6Publishing: 113] [Article Influence: 20.6] [Reference Citation Analysis]